1-2 of 2
Lesley Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System

Free
Cheng Yi Yuan, Yee W. Kong, Tess Amoore, Katrin Brown, Benyamin Grosman, Alicia Jenkins, Hannah Jones, Natalie Kurtz, Melissa H. Lee, Richard MacIsaac, Emma Netzer, Barbora Paldus, Lesley Robinson, Anirban Roy, Catriona M. Sims, Steven Trawley, Sara Vogrin, David N. O’Neal
Journal: Diabetes Care
Diabetes Care 2024;47(4):747–755
https://doi.org/10.2337/dc23-2217
Published: 21 February 2024
View articletitled, Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System
Open the PDF for Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System in another window
Journal Articles

Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial

Free
Melissa H. Lee, Barbora Paldus, Sara Vogrin, Dale Morrison, Dessi P. Zaharieva, Jean Lu, Hannah M. Jones, Emma Netzer, Lesley Robinson, Benyamin Grosman, Anirban Roy, Natalie Kurtz, Glenn M. Ward, Richard J. MacIsaac, Alicia J. Jenkins, David N. O’Neal
Journal: Diabetes Care
Diabetes Care 2021;44(10):2371–2378
https://doi.org/10.2337/dc21-0814
Published: 06 August 2021
View articletitled, Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial
Open the PDF for Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial in another window